What’s News in Markets: Defense Stocks Rise, Beer Beats, Pharma Deal

Key takeaways

U.S. actions in Venezuela are causing noteworthy movements in oil stocks.
The defense sector is rallying thanks to proposed increases in military spending.
Constellation Brands is navigating declining beer sales with strategic optimism.
Eli Lilly's acquisition of Ventix Biosciences targets a promising new treatment area.

Summary

Geopolitical Impact on Oil Stocks

The week saw significant movements in oil stocks, largely influenced by U.S. actions in Venezuela. President Trump's initiative to revive Venezuela's oil industry positively affected shares of American oil companies, with Chevron seeing a 5.1% increase on Monday and a 4% gain by week's end.

Defense Stocks Rally

The defense sector experienced notable growth following President Trump's announcement of a $1.5 trillion defense budget. This proposal led to a rally in stocks like Lockheed Martin, which reported a commitment to increase patriot missile production, resulting in a weekly gain of 9.2%.

Constellation Brands and Beer Sales Insights

Constellation Brands faced challenges in beer sales, particularly among Hispanic consumers. Although their latest results showed lower sales, they exceeded market expectations, leading to a 5.3% increase in share price. The company attributed the downturn to a combination of consumer sentiment and fewer physically demanding jobs that usually boost beer consumption.

Pharmaceutical Developments: Eli Lilly's Acquisition

Eli Lilly announced a $1 billion deal to acquire Ventix Biosciences, a move that could enhance its competitive edge in developing treatments for inflammatory responses. Ventix's focus on autoimmune conditions and obesity treatments places it in competition with notable rivals like Novo Nordisk. This acquisition led to a surge of 64% in Ventix's share price for the week.

Show notes

How American oil companies are responding following U.S. action in Venezuela? And why were Constellation investors happy with lower beer sales? Plus, how can a big pharma deal help Eli Lilly compete in a new treatment area? Host Francesca Fontana discusses the biggest stock moves of the week and the news that drove them.

Sign up for the WSJ's free Markets A.M. newsletter.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.